Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-035579
Filing Date
2022-11-10
Accepted
2022-11-10 19:39:24
Documents
2
Period of Report
2022-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1538
2 EX-24 DOCUMENT attachment1.htm EX-24 3093
  Complete submission text file 0000899243-22-035579.txt   6126
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address INTERNATIONAL FLAVORS & FRAGRANCES INC. 521 W. 57TH STREET NEW YORK NY 10019
Business Address
Epstein David R (Reporting) CIK: 0001445826 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-32405 | Film No.: 221379154